Cardiol Therapeutics Inc. (CRDL) quarterly balance sheet — complete assets, liabilities & equity history
| Total Current Assets | 31.35M | 23.5M | 12.81M | 19.77M | 25.27M | 31.67M | 17.28M | 25.88M | 30.64M | 36.15M | 31.25M | 46.65M |
| Cash & Short-Term Investments | 27.74M | 21.42M | 11.62M | 18.2M | 23.29M | 30.58M | 15.89M | 24.02M | 28.57M | 34.93M | 29.84M | 44.94M |
| Cash Only | 27.74M | 21.42M | 11.62M | 18.2M | 23.29M | 30.58M | 15.89M | 24.02M | 28.57M | 34.93M | 29.8M | 44.94M |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 45.55K | 0 |
| Accounts Receivable | 340.58K | 226.19K | 195.88K | 279.89K | 346.69K | 361.62K | 266.71K | 0 | 0 | 0 | 213.17K | 0 |
| Days Sales Outstanding | - | - | - | - | - | - | - | - | - | - | - | - |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Inventory Outstanding | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Current Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 242.42K | 317.11K | 279.87K | 0 | 305.07K |
| Total Non-Current Assets | 139.33K | 118.09K | 140.98K | 163.51K | 182.54K | 195.59K | 237.93K | 431.14K | 489.25K | 547.42K | 444.21K | 521.87K |
| Property, Plant & Equipment | 139.33K | 118.09K | 140.98K | 163.51K | 182.54K | 195.59K | 237.93K | 263.01K | 300.01K | 337.06K | 273.83K | 269.29K |
| Fixed Asset Turnover | - | - | - | - | - | - | - | - | - | - | - | - |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 168.14K | 189.25K | 210.36K | 170.38K | 252.58K |
| Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Assets | 31.49M | 23.62M | 12.95M | 19.94M | 25.45M | 31.86M | 17.52M | 26.31M | 31.13M | 36.7M | 31.69M | 47.17M |
| Asset Turnover | - | - | - | - | - | - | - | - | - | - | - | - |
| Asset Growth % | 23.7% | -25.87% | -26.1% | -24.23% | -18.22% | -13.18% | -44.72% | -44.22% | -20.1% | -19.8% | -53.64% | -36.49% |
| Total Current Liabilities | 7.15M | 5.66M | 3.29M | 8.02M | 7.75M | 7.01M | 6.95M | 10.81M | 10.92M | 8.3M | 5.91M | 8.42M |
| Accounts Payable | 0 | 0 | 0 | 7.99M | 7.72M | 6.98M | 6.92M | 9.43M | 8.85M | 7.62M | 5.09M | 6.68M |
| Days Payables Outstanding | - | - | - | - | - | 18.97K | - | 18.39K | 12.17K | 11.61K | 11.33K | 11.42K |
| Short-Term Debt | 39.89K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 21.39K | 0 |
| Deferred Revenue (Current) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 7.11M | 5.62M | 3.25M | 0 | 0 | 0 | 3.65K | 1.36M | 2.05M | 238.18K | 802.47K | 1.2M |
| Current Ratio | 4.39x | 4.16x | 3.89x | 2.46x | 3.26x | 4.52x | 2.49x | 2.39x | 2.81x | 4.36x | 5.29x | 5.54x |
| Quick Ratio | 4.39x | 4.16x | 3.89x | 2.46x | 3.26x | 4.52x | 2.49x | 2.39x | 2.81x | 4.36x | 5.29x | 5.54x |
| Cash Conversion Cycle | - | - | - | - | - | - | - | - | - | - | - | - |
| Total Non-Current Liabilities | 76.81K | 87.18K | 97.27K | 107K | 116.41K | 125.52K | 134.2K | 142.55K | 150.66K | 158.53K | 111.99K | 0 |
| Long-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Capital Lease Obligations | 76.81K | 87.18K | 97.27K | 107K | 116.41K | 125.52K | 134.2K | 142.55K | 150.66K | 158.53K | 111.99K | 0 |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Liabilities | 7.22M | 5.74M | 3.39M | 8.13M | 7.87M | 7.14M | 7.09M | 10.95M | 11.07M | 8.45M | 6.02M | 8.42M |
| Total Debt | 116.71K | 125.52K | 134.2K | 142.55K | 150.66K | 158.53K | 165.98K | 164.27K | 167.14K | 174.34K | 133.38K | 48.19K |
| Net Debt | -27.63M | -21.29M | -11.49M | -18.05M | -23.14M | -30.42M | -15.72M | -23.86M | -28.41M | -34.76M | -29.66M | -44.89M |
| Debt / Equity | 0.00x | 0.01x | 0.01x | 0.01x | 0.01x | 0.01x | 0.02x | 0.01x | 0.01x | 0.01x | 0.01x | 0.00x |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - |
| Net Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - |
| Interest Coverage | - | - | - | - | - | - | - | - | - | - | - | - |
| Total Equity | 24.27M | 17.88M | 9.56M | 11.81M | 17.59M | 24.73M | 10.43M | 15.36M | 20.06M | 28.25M | 25.67M | 38.75M |
| Equity Growth % | 37.97% | -27.7% | -8.34% | -23.13% | -12.32% | -12.45% | -59.36% | -60.36% | -40.45% | -26.65% | -56.25% | -38.35% |
| Book Value per Share | 0.22 | 0.18 | 0.11 | 0.14 | 0.21 | 0.35 | 0.15 | 0.22 | 0.30 | 0.43 | 0.40 | 0.60 |
| Total Shareholders' Equity | 24.27M | 17.88M | 9.56M | 11.81M | 17.59M | 24.73M | 10.43M | 15.36M | 20.06M | 28.25M | 25.67M | 38.75M |
| Common Stock | 213.35M | 201.87M | 187.36M | 179.54M | 179.34M | 179.34M | 154.63M | 152.35M | 151.09M | 148.52M | 108.78M | 147.67M |
| Retained Earnings | -224.47M | -213.07M | -205.9M | -195.9M | -187.54M | -179.25M | -171.7M | -158.35M | -151.76M | -142.58M | -99.33M | -129.01M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | 2.83M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3.52M | 3.52M | 2.59M | 3.52M |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |